Brief: Sprint Bioscience Q3 Operating Result Swings To Profit SEK 17.3 Million
27/10/2021 06:37
Oct 27 (Reuters) - Sprint Bioscience AB SPRINT.ST :
* Q3 NET SALES SEK 34.3 MILLION VERSUS SEK 5.2 MILLION YEAR
AGO
* Q3 OPERATING PROFIT SEK 17.3 MILLION VERSUS LOSS SEK 5.2
MILLION YEAR AGO
Source text for Eikon: ID:nWkr9cL2Fn
Further company coverage: SPRINT.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Sprint Bioscience AB
See all newsBrief: Sprint Bioscience And Max IV Receive Funding From Vinnova
Brief: Sprint Bioscience Q2 Loss After Tax SEK 16.2 Million
Brief: Sprint Bioscience Announces Deal With Lilly Tunelab
Brief: Sprint Bioscience Partners With Lilly Tunelab For Drug Development
Brief: Sprint Bioscience Q1 Operating Loss SEK 14.3 Mln